Dr. Michael Glickman

A scientist in a lab doing research. Credit: Shutterstock

$5 Million NIH Center Grant Will Support Next Generation TB Research

September 7, 2022

Weill Cornell Medicine has been awarded a five-year, $5 million grant from the National Institutes of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health to establish a new multi-institutional center for tuberculosis (TB) research and training the next generation of TB investigators.

Read full article

Center for Global Health, Dr. Carl Nathan, Dr. Daniel Fitzgerald, Dr. Jean Laurent Casanova, Dr. Jean Pape, Dr. Kyu Rhee, Dr. Michael Glickman, Dr. Sabine Ehrt, Infectious Diseases, Research, News from WCM

News from WCM

Weill Cornell Advances TB Research with Support from NIH

September 3, 2021

Tuberculosis (TB) is a wily old killer, one of the deadliest infectious diseases in history and one of the few that naturally infects only humans.

Read full article

Dr. Carl Nathan, Dr. Kyu Rhee, Dr. Michael Glickman, Dr. Sabine Ehrt, Government and Community Affairs, Graduate School of Medical Sciences, Microbiology and Immunology, Research, News from WCM

News from WCM

Study Illuminates Role of Gut Microbes in the Response to TB Treatment

March 10, 2021

Gut bacteria play an important role in the body’s response to treatment for tuberculosis (TB), according to researchers at Weill Cornell Medicine and Memorial Sloan Kettering.

Read full article

Center for Global Health, Clinical & Translational Science Center (CTSC), Dr. Carl Nathan, Dr. Daniel Fitzgerald, Dr. Julianne Imperato-McGinley, Dr. Matthew Wipperman, Dr. Michael Glickman, Graduate School of Medical Sciences, Research, News from WCM